Corvus Pharmaceuticals
CRVS
CRVS
48 hedge funds and large institutions have $34.2M invested in Corvus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
13
Reduced
11
Closed
7
Calls
$86K
Puts
$157K
Net Calls
-$71K
Net Calls Change
-$72K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$914K |
| 2 |
2
Renaissance Technologies
New York
|
$1.03M |
| 3 |
TL
3
TowerView LLC
New York
|
$769K |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$388K |
| 5 |
SC
5
Samlyn Capital
New York
|
$4.39M |
Top Sellers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$0 |
| 2 |
2
Two Sigma Investments
New York
|
$318K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$1.2K |
| 4 |
4
Millennium Management
New York
|
$71.9K |
| 5 |
5
Goldman Sachs
New York
|
$0 |
